Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

NCT05358535 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT05358535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05358535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
September 19, 2022
Completion date
March 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, anesthesia complication, anesthesia; adverse effect, anesthesia; reaction, etomidate adverse reaction, propofol adverse reaction